Skip to main content
. 2012 Jan 12;106(4):646–650. doi: 10.1038/bjc.2011.589

Figure 2.

Figure 2

Predicted median (A) PFS and (B) OS as a function of baseline FKSI-15 scores in patients on sunitinib. Abbreviations: CI=confidence interval; FKSI-15=Functional Assessment of Cancer Therapy–Kidney Symptom Index–15 item; OS=overall survival; PFS=progression-free survival.